Source
Medicine, biotech, and health policy
Health · 302 articles · page 2 of 9 · fetched 22 minutes ago
“This is not a moment our community can afford to spend fighting itself,” writes American Diabetes Association CEO…
Read at source →
The House voted to pass a stopgap funding bill that, for now, blocks a White House proposal to give political…
Read at source →
“The whole of my field has been flattened into a single lazy question: Did the health care system fail her?” writes…
Read at source →
AdSee who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
Here are some of the key questions about the agreements the Trump administration has reached with drugmakers on pricing.
Read at source →
More Trump drug pricing deals, GSK speeds up development of mRNA flu vaccine, and other biotech news
Read at source →
Novartis and Bristol Myers Squibb have paused multiple cell therapy trials, while $480,000 has now become a routine…
Read at source →
In this edition of STAT Health Tech: Stryker deploys Apple's VR headset Vision Pro for a surgical use case, chatbots…
Read at source →
New Trump drug pricing deals, weed edibles and driving research, and more health news from Morning Rounds
Read at source →
The federal spending bill has an important provision for researchers, and Trump announced more MFN deals with pharma…
Read at source →
An NIH proposal to cap the number of research grants investigators can receive has drawn a mixed reception, the agency…
Read at source →
This White House has become the paperwork administration, write Brandon Marshall and Abdullah Shihipar.
Read at source →
A key aspect of the Make America Healthy Again agenda could be hampered by a shrinking and underpaid workforce of…
Read at source →
“There has been a wealth of new treatment available” for migraine prevention, said a co-author of new guidelines…
Read at source →
President Trump on Monday announced the next round of pricing deals with drugmakers, with nine new companies making…
Read at source →
A drug patent case involving Amgen is being closely watched given its potential implications for pharmaceutical patent…
Read at source →
Another hospital system sues CVS Health, how Medicaid cuts will change everything, and more
Read at source →In today's Pharmalittle newsletter, drug pricing deals, a new cancer therapy approval, and more of the latest pharma…
Read at source →
Caution and survival in radiopharmaceuticals, mRNA skepticism, and more biotech news from The Readout
Read at source →
The mental health system after Lindsay Clancy, pushing boundaries for new radiopharmaceuticals, and more health news…
Read at source →
The latest study on CTE in football players “quantifies but does not reveal a problem,” writes Emily Harrison, a…
Read at source →
With clinical success on a personalized mRNA vaccine for melanoma, experts are hoping for a more stable future for the…
Read at source →
Researchers believe radiopharmaceuticals have great promise as cancer treatments. But are they using them too timidly?
Read at source →
Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.
Read at source →
An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.
Read at source →
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart…
Read at source →
Juul has received FDA clearance to sell an updated version of its e-cigarette, which includes an optional…
Read at source →
“We are concerned the [Lindsay] Clancy case could make psychiatrists more reluctant to treat mothers with mental…
Read at source →
Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news
Read at source →
RFK Jr.'s vaccine questions in Samoa, former Stanford president rebuts fraud allegations, and more health news from…
Read at source →Pharma news from the Pharmalot campus, brought to you by the Pharmalittle newsletter
Read at source →
It took Cytokinetics 27 years to win its first drug approval. With the results of a new trial, its second could come…
Read at source →
AstraZeneca detailed the surprise failure of a closely watched heart disease trial, a study with ripple effects for a…
Read at source →
Comments about vaccines overshadowed an advisory committee meeting to discuss a plan for boosting federal funding for…
Read at source →
Primary care is much more than what happens during an office visit, writes physician Ishani Ganguli.
Read at source →
How disease spreads and the risks and benefits of interventions are questions for science, not for ideology.
Read at source →
The FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare…
Read at source →
